News
-
-
-
-
PRESS RELEASE
EQS-Adhoc: Biotest AG: Change of the Chief Executive Officer (CEO) of Biotest AG
Biotest AG announces change of CEO. Dr. Jörg Schüttrumpf appointed new CEO, succeeding Peter Janssen by mutual agreement. Supervisory Board thanks Mr. Janssen for his past commitment. Dr. Schüttrumpf previously served on the Management Board -
-
-
PRESS RELEASE
EQS-Adhoc: FamiCord AG acquires majority stake in Národní Centrum Pupečníkové Krve and Rodinná banka perinatálnych a mezenchymálnych buniek
FamiCord AG acquires majority stake in Národní Centrum Pupečníkové Krve and Rodinná banka perinatálnych a mezenchymálnych buniek from Primecell Advanced Therapy, expanding its stem cell bank services in Europe -
PRESS RELEASE
Key Consolidated Results as of December 31, 2024
-
-